Thought leaders Dr. Steven Devine and Dr. Usama Gergis to share perspectives on unmet needs and the clinical landscape in stem cell transplant
Update on the progress of the commercial launch for. | June 14, 2023
Industry veteran Coelho brings more than 35 years of experience at emerging growth and global companies to role; Shai Lankry to leave company June 2
. | May 22, 2023
Item 1.01. Entry into a Material Definitive Agreement.
On April 19, 2023, Gamida Cell Ltd. entered into an underwriting
agreement with Piper Sandler & Co., as
representative of the several. | April 21, 2023
Gamida Cell Ltd. , a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the launch of a follow-on public offering of its ordinary shares and accompanying warrants. | April 18, 2023
Gamida Cell Ltd. announced that the U.S. Food and Drug Administration has approved Gamida Cell s allogeneic cell therapy, Omisirge® , for use in adult and pediatric patients 12 years and. | April 18, 2023